These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29508893)

  • 1. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic.
    Bakhai S; Thilagar B; Reynolds JL; Leonard KE
    J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
    Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
    J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
    Matteliano D; Chang YP
    Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
    Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
    J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
    Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
    J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter drug testing intervals are associated with improved drug misuse rates.
    Gudin J; Mehta N; McClure FL; Niles JK; Kaufman HW
    J Opioid Manag; 2020 Sep/Oct 2020; 16(5):357-373. PubMed ID: 33226093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings.
    Ceasar R; Chang J; Zamora K; Hurstak E; Kushel M; Miaskowski C; Knight K
    Subst Abus; 2016; 37(1):154-60. PubMed ID: 26682471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial.
    Liebschutz JM; Xuan Z; Shanahan CW; LaRochelle M; Keosaian J; Beers D; Guara G; O'Connor K; Alford DP; Parker V; Weiss RD; Samet JH; Crosson J; Cushman PA; Lasser KE
    JAMA Intern Med; 2017 Sep; 177(9):1265-1272. PubMed ID: 28715535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to prescription opioid monitoring guidelines among residents and attending physicians in the primary care setting.
    Khalid L; Liebschutz JM; Xuan Z; Dossabhoy S; Kim Y; Crooks D; Shanahan C; Lange A; Heymann O; Lasser KE
    Pain Med; 2015 Mar; 16(3):480-7. PubMed ID: 25529863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.